Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

88.22 +0.16 (+0.18%)
Streaming Delayed Price Updated: 11:35 AM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
Via Benzinga
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
Via Benzinga
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Performance Comparison: Boston Scientific And Competitors In Health Care Equipment &amp; Supplies Industry
Via Benzinga
Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?
BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
Via Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500. 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Via Benzinga
Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
The current leadership in the stock market is clearly not tech, or the Magnificent 7. 
Via Talk Markets
Spotlight on Boston Scientific: Analyzing the Surge in Options Activity
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $6,900 Today
Via Benzinga
In-Depth Examination Of 18 Analyst Recommendations For Boston Scientific
Via Benzinga
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
Boston Scientific Continues Bullish Sequence
Boston Scientific Corporation (BSX​​​​​​​) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular... 
Via Talk Markets
NYSE:BSX Shows Potential for a Breakout.
A technical analysis of BOSTON SCIENTIFIC CORP (NYSE:BSX) shows it may be setting up for a breakout. 
Via Chartmill
Market Analysis: Boston Scientific And Competitors In Health Care Equipment &amp; Supplies Industry
Via Benzinga
Check Out What Whales Are Doing With BSX
Via Benzinga
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Via Benzinga
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
3 Record-Breaking Stocks With More Upside Ahead
Dell, Constellation and Boston Scientific are three record-breaking stocks expected to benefit from the anticipated Fed interest rate cuts. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular Devices Leads To 2024 Guidance Hike Again
Boston Scientific reported Q2 revenue of $4.12 billion, surpassing estimates. Sales grew 14.5% reported, 16.1% operationally, and 14.7% organically. Adjusted EPS of $0.62 exceeded forecasts. Strong... 
Via Benzinga
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises
The medtech giant topped Q2 views and raised full-year guidance. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.